A detailed history of Mgo One Seven LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mgo One Seven LLC holds 1,274 shares of BIIB stock, worth $189,851. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,274
Holding current value
$189,851
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$189.07 - $236.8 $240,875 - $301,683
1,274 New
1,274 $246,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $42,959 - $51,712
193 Added 17.28%
1,310 $338,000
Q3 2023

Nov 03, 2023

SELL
$253.3 - $285.89 $59,272 - $66,898
-234 Reduced 17.32%
1,117 $287,000
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $14,037 - $16,221
-51 Reduced 3.64%
1,351 $384,000
Q1 2023

May 08, 2023

BUY
$256.56 - $292.34 $80,046 - $91,210
312 Added 28.62%
1,402 $389,000
Q4 2022

Jan 25, 2023

BUY
$252.44 - $306.72 $504 - $613
2 Added 0.18%
1,090 $0
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $211,822 - $292,084
1,088 New
1,088 $528,000
Q4 2020

Jan 22, 2021

SELL
$236.26 - $355.63 $196,568 - $295,884
-832 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$264.77 - $305.71 $220,288 - $254,350
832 New
832 $236,000
Q1 2019

Apr 09, 2019

SELL
$216.71 - $338.96 $130,676 - $204,392
-603 Closed
0 $0
Q4 2018

Jan 24, 2019

SELL
$278.5 - $352.75 $18,938 - $23,987
-68 Reduced 10.13%
603 $181,000
Q3 2018

Oct 09, 2018

BUY
$293.51 - $383.83 $58,702 - $76,766
200 Added 42.46%
671 $237,000
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $9,884 - $13,980
-38 Reduced 7.47%
471 $129,000
Q4 2017

Feb 16, 2018

BUY
$307.64 - $344.58 $156,588 - $175,391
509
509 $162,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.